Clincosm LogoSign in Get a demo

CoDiAm: Diabetes Cohort in French Amazonia

Sponsor
Centre Hospitalier de Cayenne (Other)
Overall Status
Unknown status
CT.gov ID
NCT04020068
Collaborator
(none)
3,000
Enrollment
1
Location
25
Anticipated Duration (Months)
120
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

CoDiAm aims to collect clinical, biological and social data of diabetic patients in French Guiana.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Diabetes is a very common disease in French Guiana. This disease is caused by the body's inability to metabolise sugar properly. A diet and treatment with tablets are enough for some patients, while others may need insulin injections. In the long term, high blood sugar levels may cause problems to the small and large blood vessels in the body. This is complicated by nerve, renal and retinal damage, as well as increased risks of cardiac and vascular events (such as strokes or heart attacks.) It appears that diabetes is more common and more severe in French Guiana than in other parts of France. It seems that the types of diabetes found here are more variable than those found in France, and that patients tend to be diagnosed at a later stage. We would this like to better understand diabetes and its evolution in French Guiana.

    This research is aimed at diabetic patients and it is being carried out in the Andrée Rosemon Hospital Centre, the Ouest Guyanais Hospital Centre as well as in other Primary Healthcare Centres. At some point in the future, some private health centres may also invite their patients to take part in this study.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    3000 participants
    Observational Model:
    Other
    Time Perspective:
    Cross-Sectional
    Official Title:
    Diabetes Cohort in French Amazonia
    Actual Study Start Date :
    Apr 8, 2019
    Anticipated Primary Completion Date :
    Apr 8, 2021
    Anticipated Study Completion Date :
    May 8, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Improvement of patient care [2 years]

      Number of health complications in diabetes mellitus ...

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Patients with diabetes

    • At least 18 years old

    Exclusion Criteria:

    • Less than 18 years old

    • Patients under legal guardianship

    • Patients' refusal to participate

    • Patients living outside French Guiana

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Centre Hospitalier de Cayenne Cayenne French Guiana France 97306

    Sponsors and Collaborators

    • Centre Hospitalier de Cayenne

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Centre Hospitalier de Cayenne
    ClinicalTrials.gov Identifier:
    NCT04020068
    Other Study ID Numbers:
    • CODIAM
    First Posted:
    Jul 15, 2019
    Last Update Posted:
    Jul 15, 2019
    Last Verified:
    Jul 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Centre Hospitalier de Cayenne
    Diabete
    French Guiana
    Additional relevant MeSH terms:
    Diabetes Mellitus

    Study Results

    No Results Posted as of Jul 15, 2019